BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24387290)

  • 1. XB130 promotes proliferation and invasion of gastric cancer cells.
    Shi M; Zheng D; Sun L; Wang L; Lin L; Wu Y; Zhou M; Liao W; Liao Y; Zuo Q; Liao W
    J Transl Med; 2014 Jan; 12():1. PubMed ID: 24387290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway.
    Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L
    J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li GM; Liang CJ; Zhang DX; Zhang LJ; Wu JX; Xu YC
    Chin Med J (Engl); 2018 Oct; 131(19):2320-2331. PubMed ID: 30246718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
    PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
    Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
    Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
    Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling.
    Lin JX; Xie XS; Weng XF; Qiu SL; Yoon C; Lian NZ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Huang CM; Zheng CH; Li P
    J Exp Clin Cancer Res; 2019 Sep; 38(1):410. PubMed ID: 31533855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer.
    Chen J; Wang T; Zhou YC; Gao F; Zhang ZH; Xu H; Wang SL; Shen LZ
    J Exp Clin Cancer Res; 2014 May; 33(1):38. PubMed ID: 24887009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB.
    Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y
    Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.